Cargando…
Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update
SIMPLE SUMMARY: Glioblastoma multiforme (GBM) are among the most lethal tumors. The highly invasive nature and presence of GBM stem cells, as well as the blood brain barrier (BBB) which limits chemotherapeutic drugs from entering the tumor mass, account for the high chance of treatment failure. Rece...
Autores principales: | Hsu, Jen-Fu, Chu, Shih-Ming, Liao, Chen-Chu, Wang, Chao-Jan, Wang, Yi-Shan, Lai, Mei-Yin, Wang, Hsiao-Chin, Huang, Hsuan-Rong, Tsai, Ming-Horng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827410/ https://www.ncbi.nlm.nih.gov/pubmed/33430494 http://dx.doi.org/10.3390/cancers13020195 |
Ejemplares similares
-
Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018) -
Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017) -
Impacts of Multidrug-Resistant Pathogens and Inappropriate Initial Antibiotic Therapy on the Outcomes of Neonates with Ventilator-Associated Pneumonia
por: Wang, Hsiao-Chin, et al.
Publicado: (2020) -
Clinical characteristics and outcomes of neonates with polymicrobial ventilator-associated pneumonia in the intensive care unit
por: Wang, Hsiao-Chin, et al.
Publicado: (2021) -
Multidrug-Resistant Healthcare-Associated Infections in Neonates with Severe Respiratory Failure and the Impacts of Inappropriate Initial Antibiotic Therap
por: Hsu, Jen-Fu, et al.
Publicado: (2021)